



The Dose Dependence Analysis of the Water 
Fraction of merremia mammosa (lour.) Extract on 
Diabetic wound Healing Enhancement 
 
Ancah Caesarina Novi MARCHIANTI1*, Evi Umayah ULFA2, Elly Nurus SAKINAH3 
 
1Department of Public Health, Medical Faculty, University of Jember 
2Department of Microbiology and Pharmaceutical Biotechnology, Pharmacy Faculty, University 
of Jember 




Introduction: Diabetic wounds or ulcers happened in Indonesia’s hospitalized diabetes 
patients range from 17.3 to 32.9%. The high cost of treatment, the high risk of amputation 
and the difficulty of handling diabetic wounds, make it necessary to look for alternative 
medicine derived from plants e.g. Merremia mammosa (Mm). This study aimed to analyze 
the potential dose of the water fraction of Mm (Lour.) extract on diabetic wound healing 
enhancement. Method: This study used fifty-seven male wistar rats that were made 
diabetic by intraperitoneal injection of 40 mg/kg body weight streptozotocin. Rats divided 
into six groups equally, which consist of positive control (gentamicin 0.1%), negative control 
(aquadest) and water fraction of Mm (Lour.) extract dose 12.5 mg, 25 mg, 50 mg and 100 
mg. Wound was made by Morton method and treatment applied on the wound every other 
day for 21 days. Wound healing process were observed by percent wound healing and 
histopathological changings on day 0, 3, 10 and 25, representing each healing phase. 
Results: The percentage of reduction in wound size comparison at day 10 showed no 
significant different when compared with positive control started from dose 50 mg. This 
result is consistent with the histopathological changings parameter (angiogenesis, 
macrophage, fibroblast and collagen density). Conclusion: Water fraction of Mm (Lour.) 
extract was dose-dependently enhanced the process of wound healing in diabetic rat model 
and the most effective dose was 100 mg, which looks similar with positive control. Therefore, 
it is potential to be developed further as a topical drug.  
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The process of wound healing in Diabetes 
Mellitus (DM) patients are longer than 
normal injuries due to disruption of all 
processes of wound healing (1). Continuous 
hyperglycaemic conditions, pro-
inflammatory environments, peripheral 
arterial disease, and peripheral neuropathy 
simultaneously cause impaired immune 
function, ineffective inflammatory responses, 
endothelial cell dysfunction, and 
neovascularization disorders (2). Increased 
sugar levels in collagen synthesis, worsening 
epithelization, decreased angiogenesis in the 
proliferation phase and fibroblasts caused 
extracellular matrix was not formed 
maximally because the circulatory and 
oxygen distribution to the region were 
disrupted (3). Diabetic injuries that do not 
treat well will rapidly expand to bacterial 
infections and in further circumstances will 
cause diabetic gangrene. Diabetic gangrene 
is a form of tissue in patients with DM due to 
reduced or cessation of blood flow to the 
tissue. 
The management of diabetic injuries is 
complex because it requires comprehensive 
and multidisciplinary handling. Wound care 
in patients with DM is done with the aim to 
prevent the occurrence of infection, 
accelerate wound healing and reduce the risk 
of amputation. The effectiveness of wound 
care can be seen through changes in wound 
area, repair of wound severity, wound 
healing time and complete wound healing (4). 
Management of diabetic injuries include 
overcoming comorbid diseases (hypertension 
and atherosclerosis), reducing the burden 
(offloading), keeping the wound always moist 
(moist), handling infections and 
debridement. Skin moisture is needed to 
accelerate the process of tissue re-
epithelization through stimulation of 
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proliferation and epithelial cell migration 
and growth factor growth (5). 
Mm (Lour.) is one of medicinal plants from 
Indonesia that can be found in Meru Betiri 
National Park. Derived from Convolvuraceae 
family, it can be used as an anti-
inflammatory, analgesic, wound healer, 
treating snake bites, cancer, leprosy, syphilis, 
typhoid, diphtheria, inflammation and 
diabetes (6, 7). Upper luminous tubs contain 
polysaccharides, flavonoids and glycoside 
resin compounds such as meremocides A, E, 
J, mammosa that have activity as 
antibacterial by hollowing the cell membrane 
(8). Agil et al, 2011 and Sugijanto et al, 2012 
reported research on extract of the Mm 
(Lour.) showed an ability to inhibit the 
growth of pathogenic bacteria of 
Microbacterium tuberculosis, Salmonella 
typhi, Staphylococcus aureus (research 
report). It is also capable on lowering blood 
sugar levels in diabetic rats with impaired 
glucose tolerance (Tilaqza, 2009, unpublished 
script).  
The same genus with Mm namely 
Merremia tridenta has been shown to have 
activity as wound healer, (9) anti-diabetic, 
anti-hyperlipidemic, antioxidant and anti-
inflammatory (10, 11). Our preliminary study 
with the Mm (Lour.) extract has shown that 
healing process significantly enhance at day 
7 of the treatment and water fraction was the 
most effective fraction of Mm (Lour.) extract 
among the ethyl acetat, n hexane and water 
fraction on diabetic wound healing 
enhancement (unpublished data). Using 
chemotaxonomic approach with the plant in 
the same family or genus of similar 
compounds and the possibility of having 
almost the same efficacy and empirical usage 
of Mm (Lour.), this research aims to analyze 
the potential dose of the water fraction of Mm 
(Lour.) extract on diabetic wound healing 
enhancement. 
 
MATERIALS AND METHODS 
Experimental animals 
Albino Wistar rats of male sex in early 
adulthood weighing between 150-200 g were 
used in the present study. Rats kept in an 
individual cage with a standard feed of ad 
libitum food and water. Mice adapted to the 
condition for 1 week. The mice were induced 
using Streptozotocin (STZ) dissolved in 0.05 
mol / L buffer citrate (pH 4.5) with a single 
dose of 40 mg / kg body weight. The mice had 
diabetes when blood glucose levels exceeded 
300mg/dL on the fifth day after STZ injection 
(12). Blood glucose levels were measured using 
Glucose meter (Easytouch, Taiwan) once a 
week. The experimental protocol was 
approved by Institutional Animal Ethics 
Committee and animals were maintained 
under standard conditions in an animal 
house approved by Ethic Committee. 
 
Formulation of water fraction of Mm 
(Lour.) extract 
The viscous ethanol extract of Mm (Lour.) 
was fractionated by partition using 3 
different solvents of polarity i.e. n hexane, 
ethyl acetate and water. 50 g of condensed 
extract added with 100 mL of water and 
stirred until homogeneous. This water 
fraction is subsequently in a successive 
partition using n hexane and ethyl acetate 
with a ratio of 2: 3. The fractionation is 
performed by 3 repetitions. The water 
fraction is then concentrated by a freeze 
dryer. 
Effect on excision wound 
Animals were anesthetized using ketamin 
(50 mg/kg) and xylazine (10 mg/kg) injected 
intramuscular. An impression was made on 
the dorsal thoracic region 1 cm away from 
vertebral column on the anaesthetized rat. 
Particular skin area was shaved and the skin 
of impressed area was excised to the full 
thickness to obtain a rectangle wound area of 
about 25x25 mm.13 Animals were then 
grouped (n = 9 per group) and treated 
topically as follows: Group C(+): Control 
positive with gentamycin 0.1%, Group C(-): 
Control negative with aquadest, and the rest 
are with water fraction of Mm (Lour) extract 
dose 12.5 mg (T1), 25 mg (T2), 50 mg (T3) and 
100 mg (T4) every other day for 21 days. The 
wound was left undressed to the open 
environment. Wound area was measured by 
tracing the wound on a millimeter scale 
graph paper. Percentage of wound healing 
was calculated as original wound size as for 
each animal of the group on predetermined 
days i.e, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 
25 days post-wounding.  
Histopathology 
Histopathological parameter observed on 
days 0, 3, 10 and 25 (n=3 per group per day) 
representing the wound healing phase 
(inflammation, proliferation and 
remodeling). The mice were sacrificed on 
those days with cervical dislocation and 
excision was performed to obtain tissue for 
histopathologic examination with 
hematoxylin-eosin stain. The tissue was 




observed under a light microscope (Olympus 
trinocular type 31X) at 5 large fields (400X) 
and photographed to assess angiogenesis, 
macrophage, fibroblast density and collagen 
density degree and expressed in the scoring 
system. The scoring of the parameters 
mentioned above was determined as absent 
(0) when it was between 0-10%; mild (1) when 
it was between 10-40 %; moderate (2) when it 
was between 40-70% and severe (3) when it 
was between 70-100%.5 In addition, 
extracellular matrix (ECM) represent 
collagen fiber density was also being assessed 
using ImageJ software, described as 
percentage (13). 
Statistical analysis  
The data obtained were analyzed using 
unpaired Student’s t-test to identify 
significant differences between group using 
Excel software from Microsoft Office 
Profesional Plus 2016. Values are shown as 
the mean ± standard error (SE). 
 
RESULTS 
Body weight and non-fasting blood 
glucose 
The data obtained showed that each group 
has similar body weight changing pattern. As 
shown in Figure 1A, after induction the rat 
body weight increase for a week, slightly 
decrease on day 3 of the excision and return 
to gain weight until the day of sacrificed. As 
shown in Figure 1B, the non-fasting blood 
glucose increased to more than 300 mg/dl five 
days after injection of STZ and maintain 
above 300 mg/dl until the day of sacrificed.  
 
Wound healing 
The average measurement of percent wound 
healing from day to day on a macroscopic 
basis among the wound given gentamycin 
0.1%, aquadest and the water fraction of Mm 
(Lour) extract several doses can be seen in 
the table 1 where the percent wound healing 
on day 10 showed no significant different 
with positive control starting from dose 50 
mg. For a clearer result, Figure 1C showed 
the percent wound healing measured every 
two days of the rats kept until day 25 (n=3).  
 
Histopathology 
Histopathological parameter in all 
experimental group during the experimental 
period summarizes in table 2. It showed that 
on day 10 and 25 the collagen fiber have 
significant different in all group except T1 on 
day 10 when comparing with C(-) and no 
significant different when comparing with 
C(+). Description of histopathological 
parameter by photomicrograph in each 
healing phase can be seen in figure 2 which 
there were no significant different yet on day 
0 and 3 of wound excision. 
 
DISCUSSIONS 
Wound healing is a complex process that 
involves interactions between cells, ECM, 
growth factor, and cytokines. Wound healing 
process consists of three stages i.e. 
inflammation, angiogenesis (proliferation) 
and remodeling (14). Diabetic wound possibly 
developing in difficult-to-heal wounds 
(wounds still proceeding through the wound 
healing stages but at an exceedingly slow 
rate), although such wounds have not been 
well studied (11, 15). This study demonstrated 
that water fraction of Mm (Lour) extract 
enhances excisional diabetic wound healing, 
as defined by a more rapid of healing phase 
showed by faster percent wound healing and 
faster formation of ECM that mostly consist 
of collagen. In particular, the assessment of 
histopathological parameter revealed an 
advantage for the groups primed with water 
fraction of Mm (Lour) extract in comparison 
to the control animals. The time needed to 
achieve 50% closure of the wound decreased 
from 7.7 ± 1.0 days in control negative to 5.6 
± 0.6 in water fraction of Mm (Lour) extract 
dose 100 mg (data not shown). This is 
consistent with our previous study on Mm 
(Lour) extract.8 Therefore, the findings in 
this study allow the presumption that local 
Mm (Lour) treatment may be a novel and 
clinically applicable treatment for enhancing 
wound healing in diabetic wounds.  
A number of studies have reviewed the use of 
natural plants as local treatment for wound 
healing but to our knowledge this is the first 
to be done with water fraction of Mm (Lour) 
extract (8, 16, 17). The ethanol extract used in 
the previous study was still contained all the 
components of Mm (Lour) which gave effect 
as well as those not on wound healing. The 
amount of extract required is still large (200 
mg) because the active components are still 
mixed with other components that are not 
active. Fractionation or stratified 
purification of uptake extract performed to 
increase the yield of the active component 
and decrease the amount of non-active 
material contaminant in the extract. Non-
active material removal is also expected to 
facilitate in the formulation phase to improve 




the acceptability of the preparation. It can 
also be used to minimize unwanted effects 
from impurities. In an immunomodulatory 
preparation contained active meniran 
extract, fractionation is proven to be able to 
eliminate the unwanted effects of diuretics. 
Wound healing percentage showed that the 
effective dose started from 50 mg (no 
significant different with the positive control 
at day 10, n=3) and the effect increased by 
increasing the dose into 100 mg. But when we 
examine histopathology parameter, it is 
described that dose 25 mg already showed 
wound healing enhancement by evaluating 
the ECM enhancement on day 10. There is no 
significant different can be seen in other 
histopathology parameters probably due to 
the limited number of samples and the data 
were not fully quantitative. While the other 
groups showed low density of all examined 
histopathology parameters, negative control 
group showed a still high density of ECM, at 
day 25, that significantly different with all 
other group. This is because the negative 
control has a prolonged phase of healing, 
relevant with the result of Ackermann et al 
study on diabetic wound.1 However, although 
showed trend of delayed healing process at 
day 10, negative control wound healing 
percentage was not reached any significant 
different (n=3) when comparing with all 
other group, including the positive control 
(p=0.08), probably due to high variation in 
control negative data that shown by higher 
standard error. This variation may be the 
result of individual non-treatment 
inflammatory response differences that 
related to various factors, i.e. epidermal 
barrier function, growth factor production, 
etc (1).  
Some of the content of Mm (Lour) are 
polyphenols such as flavonoids. Flavonoids 
have antioxidant effects that accelerate the 
inflammatory phase by capturing free 
radicals and prevent oxidation reactions by 
increasing the activity of the enzyme 
Superoxide dismutase (SOD) and glutathione 
transferase (Subandi, et al., research report). 
In addition, flavonoids have anti-
inflammatory activity that inhibits the 
important phase in biosynthesis that is on 
the path of cyclooxygenase and an 
antibacterial activity by inhibited bacterial 
DNA gyrase function so that the replication 
and translation of bacteria is inhibited 
(Gunawan, 2009, unpublished script). 
Flavonoids with their anti-inflammatory 
activity can stimulate cells such as 
macrophages to produce growth factors and 
cytokines such as EGF, TGF-β, IL-1, IL-4, IL-
8 to accelerate the proliferation and other 
wound healing phase. The content of 
flavonoids in Mm (Lour) can also stimulate 
cellular immunity by proliferating 
lymphocytes and production of reactive 
oxygen intermediate macrophages (Farizal, 
2012, unpublished script). 
Diabetic rats model in this study were 
maintained to have severe diabetes because 
the STZ dose administered at 40 mg/kg body 
weight and the non-fasting blood glucose 
higher than 300 mg/dL through all the 
experiment period (Figure 1) (12). Body weight 
in all group showed a slightly decreased right 
after STZ injection and then increased 
gradually, this is relevant with DM 
pathogenesis (18, 19). 
Although the researcher has tried 
maximally to control every step in conducting 
this research, there were still few limitations 
such as the method in measuring wound size 
and grading the density of angiogenesis, 
macrophage, fibroblast and collagen that was 
done by manual measurement. The usage of 
ImageJ software also has a limit to only 
differentiate the ECM and cannot be specific 
in collagen structure. 
 
CONCLUSIONS 
Diabetic wound possibly developing in 
difficult-to-heal wounds, therefore, it need a 
special treatment. Based on the result of data 
analysis, water fraction of Mm (Lour.) extract 
was dose-dependently enhancing the process 
of wound healing in diabetic rat model and 
the most effective dose was 100 mg, which 
looks similar with positive control. When 
comparing with negative control there is no 
group significantly different including the 
positive control, probably due to high 
variation in control group related to severity 
variation of DM. According to the purpose of 
this research, it is suggested to develop the 
effective dose of Mm (Lour) extract water 
fraction as a topical drug in diabetic wound 
or other prolonged wound healing conditions. 
However, to overcome the limitation of this 
study, it is suggested to conduct future 
research with larger number of samples and 
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